Contributors |
|
xiii | |
Foreword |
|
xxxiii | |
Preface |
|
xxxv | |
|
SECTION 1 Foundation Issues |
|
|
1 | (22) |
|
|
|
|
|
1 | (8) |
|
|
|
|
e2 Health Literacy and Medication Use |
|
|
9 | (2) |
|
|
|
|
e3 Exploring Cultural Diversity and Equity in Healthcare |
|
|
11 | (2) |
|
|
|
|
|
Jessica M. Shenberger-Trujillo |
|
|
|
13 | (2) |
|
|
|
15 | (2) |
|
|
|
|
e6 Clinical Pharmacokinetics and Pharmacodynamics |
|
|
17 | (2) |
|
|
|
e7 Clinical Pharmacogenomics |
|
|
19 | (2) |
|
|
|
|
|
21 | (2) |
|
|
|
SECTION 2 Common Health Problems |
|
|
23 | (44) |
|
|
|
|
|
23 | (2) |
|
|
|
|
25 | (2) |
|
|
|
|
e11 Minor Ophthalmic Disorders |
|
|
27 | (2) |
|
|
e12 Minor Otic Disorders (Cerumen Impaction, Otitis External) |
|
|
29 | (2) |
|
|
e13 Nonspecific Respiratory Tract Symptoms (with Cough) |
|
|
31 | (2) |
|
|
|
33 | (2) |
|
|
e15 Oral Health and Systemic Conditions |
|
|
35 | (2) |
|
|
|
e16 Ora' Hygiene and Minor Oral Disorders |
|
|
37 | (2) |
|
|
|
|
e17 Skin Care and Minor Dermatologic Conditions |
|
|
39 | (2) |
|
|
|
|
41 | (2) |
|
|
|
|
43 | (24) |
|
|
SECTION 3 Special Populations |
|
|
67 | (18) |
|
|
|
e20 Pediatrics: General Topics in Pediatric Pharmacotherapy |
|
|
67 | (2) |
|
|
|
e21 Pediatrics: Oral Nutrition and Rehydration of Infants and Children |
|
|
69 | (2) |
|
|
e22 Pediatrics: Neonatal Critical Care |
|
|
71 | (2) |
|
|
|
e23 Geriatrics: Physiology of Aging |
|
|
73 | (2) |
|
|
|
|
|
e24 Geriatrics: Medication Use in Older Adults |
|
|
75 | (2) |
|
|
|
|
e25 Geriatrics: Assessing Health and Delivering Healthcare to Older Adults |
|
|
77 | (2) |
|
|
|
|
e26 Critical Care: Considerations in Medication Selection, Dosing, Monitoring, and Safety |
|
|
79 | (2) |
|
|
|
e27 Critical Care: Pain, Agitation, and Delirium |
|
|
81 | (2) |
|
|
|
e28 Palliative and End-of-Life Care |
|
|
83 | (2) |
|
|
|
SECTION 4 Cardiovascular Disorders |
|
|
85 | (270) |
|
|
e29 Evaluation of Cardiovascular Function |
|
|
85 | (2) |
|
|
|
|
|
87 | (32) |
|
|
|
e31 Acute Hypertensive Crisis |
|
|
119 | (2) |
|
|
|
|
|
121 | (22) |
|
|
|
|
33 Stable Ischemic Heart Disease |
|
|
143 | (24) |
|
|
|
|
34 Acute Coronary Syndrome |
|
|
167 | (30) |
|
|
|
|
e35 Peripheral Arterial Disease |
|
|
197 | (2) |
|
|
|
|
199 | (32) |
|
|
|
37 Acute Decompensated Heart Failure |
|
|
231 | (20) |
|
|
|
|
38 Venous Thromboembolism |
|
|
251 | (32) |
|
|
|
|
|
283 | (14) |
|
|
|
|
297 | (38) |
|
|
|
|
41 Cardiopulmonary Arrest |
|
|
335 | (18) |
|
|
|
353 | (2) |
|
|
|
|
SECTION 5 Respiratory Disorders |
|
|
355 | (102) |
|
|
e43 Evaluation of Respiratory Function |
|
|
355 | (2) |
|
|
|
|
|
|
357 | (36) |
|
|
|
45 Chronic Obstructive Pulmonary Disease |
|
|
393 | (26) |
|
Sharya V. Bourdetand Dennis M. Williams |
|
|
46 Pulmonary Arterial Hypertension |
|
|
419 | (18) |
|
Rebecca L. Attridge Rebecca Moote |
|
|
|
|
437 | (18) |
|
|
|
|
e48 Drug-Induced Pulmonary Diseases |
|
|
455 | (2) |
|
|
|
SECTION 6 Gastrointestinal Disorders |
|
|
457 | (162) |
|
|
e49 Evaluation of the Gastrointestinal Tract |
|
|
457 | (2) |
|
|
50 Gastroesophageal Reflux Disease |
|
|
459 | (20) |
|
|
|
|
51 Peptic Ulcer Disease and Related Disorders |
|
|
479 | (24) |
|
|
52 Inflammatory Bowel Disease |
|
|
503 | (22) |
|
|
|
525 | (14) |
|
|
|
|
54 Diarrhea, Constipation, and Irritable Bowel Syndrome |
|
|
539 | (18) |
|
|
|
55 Portal Hypertension and Cirrhosis |
|
|
557 | (16) |
|
|
e56 Drug-Induced Liver Injury |
|
|
573 | (2) |
|
|
|
|
575 | (16) |
|
|
|
591 | (20) |
|
|
|
611 | (8) |
|
|
|
SECTION 7 Renal Disorders |
|
|
619 | (204) |
|
|
e60 Evaluation of Kidney Function |
|
|
619 | (2) |
|
|
|
|
621 | (20) |
|
|
|
|
62 Chronic Kidney Disease |
|
|
641 | (12) |
|
|
63 Chronic Kidney Disease: Management of Secondary Complications |
|
|
653 | (26) |
|
|
64 Hemodialysis and Peritoneal Dialysis |
|
|
679 | (20) |
|
|
|
65 Drug-Induced Kidney Disease |
|
|
699 | (20) |
|
|
|
|
719 | (2) |
|
|
67 Personalized Pharmacotherapy for Patients with Chronic Kidney Disease |
|
|
721 | (16) |
|
|
|
68 Disorders of Sodium and Water Homeostasis |
|
|
737 | (26) |
|
|
|
69 Disorders of Calcium and Phosphorus Homeostasis |
|
|
763 | (20) |
|
|
70 Disorders of Potassium and Magnesium Homeostasis |
|
|
783 | (18) |
|
|
|
801 | (22) |
|
|
|
SECTION 8 Neurologic Disorders |
|
|
823 | (178) |
|
|
e72 Evaluation of Neurological Illness |
|
|
823 | (2) |
|
|
|
|
825 | (20) |
|
|
|
|
|
|
|
845 | (24) |
|
|
|
|
|
|
|
869 | (36) |
|
|
|
|
|
905 | (16) |
|
|
|
|
77 Acute Management of the Brain Injury Patient |
|
|
921 | (14) |
|
|
|
|
935 | (18) |
|
|
|
|
|
953 | (28) |
|
|
|
|
|
981 | (20) |
|
|
|
SECTION 9 Psychiatric Disorders |
|
|
1001 | (202) |
|
|
e81 Evaluation of Psychiatric Illness |
|
|
1001 | (2) |
|
|
|
|
|
82 Attention Deficit Hyperactivity Disorder |
|
|
1003 | (20) |
|
|
|
|
|
1023 | (2) |
|
|
|
|
e84 Introduction to Substance Use Disorders |
|
|
1025 | (2) |
|
|
|
|
85 Substance Use Disorders I: Opioids, Cannabis, and Stimulants |
|
|
1027 | (20) |
|
|
|
|
86 Substance Use Disorders II: Alcohol, Nicotine, and Caffeine |
|
|
1047 | (26) |
|
|
|
|
1073 | (34) |
|
|
|
|
|
1107 | (26) |
|
|
|
1133 | (18) |
|
|
|
90 Generalized Anxiety Disorder, Panic Disorder, and Social Anxiety Disorder |
|
|
1151 | (22) |
|
|
|
91 Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder |
|
|
1173 | (14) |
|
|
|
|
|
1187 | (14) |
|
|
|
e93 Developmental Disabilities |
|
|
1201 | (2) |
|
|
SECTION 10 Endocrinologic Disorders |
|
|
1203 | (88) |
|
|
|
1203 | (36) |
|
|
|
|
1239 | (2) |
|
|
|
|
|
1241 | (26) |
|
|
|
97 Adrenal Gland Disorders |
|
|
1267 | (22) |
|
|
Christopher R. Piszczatoski |
|
|
|
e98 Pituitary Gland Disorders |
|
|
1289 | (2) |
|
|
|
|
SECTION 11 Gynecologic and Obstetric Disorders |
|
|
1291 | (74) |
|
|
99 Pregnancy and Lactation |
|
|
1291 | (22) |
|
|
|
100 Menstrual-Related Disorders |
|
|
1313 | (20) |
|
|
|
|
1333 | (10) |
|
|
|
102 Menopausal Hormone Therapy |
|
|
1343 | (22) |
|
|
|
SECTION 12 Urologic Disorders |
|
|
1365 | (66) |
|
|
|
1365 | (28) |
|
|
|
104 Benign Prostatic Hyperplasia |
|
|
1393 | (20) |
|
|
|
|
1413 | (18) |
|
|
|
|
SECTION 13 Immunologic Disorders |
|
|
1431 | (50) |
|
|
|
e106 Function and Evaluation of the Immune System |
|
|
1431 | (2) |
|
|
|
107 Systemic Lupus Erythematosus |
|
|
1433 | (22) |
|
|
|
1455 | (2) |
|
|
|
|
109 Solid-Organ Transplantation |
|
|
1457 | (24) |
|
|
|
|
SECTION 14 Rheumatologic Disorders |
|
|
1481 | (96) |
|
|
|
|
1481 | (20) |
|
|
|
|
1501 | (22) |
|
|
|
|
|
1523 | (32) |
|
|
|
|
|
113 Gout and Hyperuricemia |
|
|
1555 | (22) |
|
|
|
SECTION 15 Ophthalmic Disorders |
|
|
1577 | (34) |
|
|
|
1577 | (18) |
|
|
|
|
115 Age-Related Macular Degeneration |
|
|
1595 | (14) |
|
|
|
e116 Drug-Induced Ophthalmic Disorders |
|
|
1609 | (2) |
|
|
SECTION 16 Dermatologic Disorders |
|
|
1611 | (84) |
|
|
|
1611 | (28) |
|
|
|
|
1639 | (22) |
|
|
|
|
1661 | (16) |
|
|
|
|
1677 | (16) |
|
|
|
|
e121 Dermatologic Drug Reactions, Contact Dermatitis, and Common Skin Conditions |
|
|
1693 | (2) |
|
|
|
|
SECTION 17 Hematologic Disorders |
|
|
1695 | (60) |
|
|
|
1695 | (20) |
|
|
|
123 Coagulation Disorders |
|
|
1715 | (18) |
|
|
|
|
|
1733 | (20) |
|
|
|
|
e125 Drug-Induced Hematologic Disorders |
|
|
1753 | (2) |
|
|
|
SECTION 18 Infectious Diseases |
|
|
1755 | (400) |
|
|
e126 Laboratory Tests to Direct Antimicrobial Pharmacotherapy |
|
|
1755 | (2) |
|
|
|
|
127 Antimicrobial Regimen Selection |
|
|
1757 | (14) |
|
|
|
128 Central Nervous System Infections |
|
|
1771 | (20) |
|
|
|
|
|
129 Lower Respiratory Tract Infections |
|
|
1791 | (22) |
|
|
|
130 Upper Respiratory Tract Infections |
|
|
1813 | (12) |
|
|
|
|
|
1825 | (14) |
|
|
e132 Coronavirus Disease (COVID-19) |
|
|
1839 | (2) |
|
|
|
|
133 Skin and Soft Tissue Infections |
|
|
1841 | (28) |
|
|
134 Bacteremia and Infective Endocarditis |
|
|
1869 | (24) |
|
|
|
1893 | (20) |
|
|
|
136 Gastrointestinal Infections and Enterotoxigenic Poisonings |
|
|
1913 | (16) |
|
|
|
137 Intra-Abdominal Infections |
|
|
1929 | (18) |
|
|
|
|
e138 41 Parasitic Diseases |
|
|
1947 | (2) |
|
|
|
|
139 Urinary Tract Infections |
|
|
1949 | (18) |
|
|
|
140 Sexually Transmitted Infections |
|
|
1967 | (22) |
|
|
|
141 Bone and Joint Infections |
|
|
1989 | (14) |
|
|
|
142 Sepsis and Septic Shock |
|
|
2003 | (18) |
|
|
|
143 Superficial Fungal Infections |
|
|
2021 | (18) |
|
|
|
144 Invasive Fungal Infections |
|
|
2039 | (28) |
|
|
|
145 Infections in Immunocompromised Patients |
|
|
2067 | (32) |
|
|
|
146 Antimicrobial Prophylaxis in Surgery |
|
|
2099 | (16) |
|
|
147 Vaccines and Immunoglobulins |
|
|
2115 | (14) |
|
|
148 Human Immunodeficiency Virus Infection |
|
|
2129 | (26) |
|
|
|
|
SECTION 19 Oncologic Disorders |
|
|
2155 | (300) |
|
|
149 Cancer: The Disease and Treatment |
|
|
2155 | (54) |
|
|
|
150 Supportive Care in Cancer |
|
|
2209 | (20) |
|
|
|
|
2229 | (26) |
|
|
|
|
|
2255 | (22) |
|
|
|
|
2277 | (26) |
|
|
|
|
|
2303 | (20) |
|
|
|
|
2323 | (28) |
|
|
|
|
|
2351 | (18) |
|
|
|
|
2369 | (22) |
|
|
|
|
2391 | (20) |
|
|
|
|
2411 | (18) |
|
|
|
e160 Myelodysplastic Syndromes |
|
|
2429 | (2) |
|
|
|
e161 Renal Cell Carcinoma |
|
|
2431 | (2) |
|
|
|
|
2433 | (20) |
|
|
|
e163 Hematopoietic Cell Transplantation |
|
|
2453 | (2) |
|
|
|
SECTION 20 Nutritional Disorders |
|
|
2455 | (90) |
|
|
164 Assessment of Nutrition Status and Nutrition Requirements |
|
|
2455 | (26) |
|
|
|
e165 Parenteral Nutrition |
|
|
2481 | (20) |
|
|
|
|
2501 | (18) |
|
|
|
2519 | (26) |
|
|
|
Index |
|
2545 | |